Experimental stem cell therapy tried in 84-Year-Old stroke patient

NCT ID NCT04907188

NO_LONGER_AVAILABLE Disease control Sponsor: Hope Biosciences Research Foundation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a stem cell treatment (HB-adMSCs) in one 84-year-old man who had a stroke. The cells were taken from his own fat tissue and given through an IV every 28 days for 6 doses. The goal was to see if it was safe and could help him recover. The study is no longer available and was not designed to prove the treatment works for everyone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: autologous HB-adMSCs (stem cells from the patient's own fat tissue)
What this could lead to: If it works, this could point toward a treatment that helps stroke patients recover by repairing brain damage.
What could go wrong: This is a single-patient expanded access study, not a full clinical trial. Results may not apply to others, and the treatment is still experimental with unknown risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic disease ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STROKE STROKE, ISCHEMIC

Contacts and locations

Locations

Hope Biosciences Stem Cell Research Foundation

Sugar Land, Texas, 77478, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.